{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T18:31:45Z","timestamp":1790706705114,"version":"4.1.0"},"reference-count":56,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100004410","name":"Scientific and Technological Research Council of Turkey","doi-asserted-by":"publisher","award":["221Z114"],"award-info":[{"award-number":["221Z114"]}],"id":[{"id":"10.13039\/501100004410","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Bioorganic Chemistry"],"published-print":{"date-parts":[[2025,9]]},"DOI":"10.1016\/j.bioorg.2025.108903","type":"journal-article","created":{"date-parts":[[2025,8,21]],"date-time":"2025-08-21T20:25:42Z","timestamp":1755807942000},"page":"108903","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"special_numbering":"C","title":["Synthesis and evaluation of sulfonamide-chalcone hybrid compounds as inhibitors of VEGFR1\/VEGFR2-mediated angiogenesis"],"prefix":"10.1016","volume":"164","author":[{"given":"Neslisah","family":"Barlak","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fatma","family":"Sanli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Suleyman","family":"Celik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Burhan","family":"\u0130skender","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Derya Aktas","family":"Anil","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicola","family":"Gambacorta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Serdar","family":"Burmaoglu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Orazio","family":"Nicolotti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Oztekin","family":"Algul","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Omer Faruk","family":"Karatas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"4","key":"10.1016\/j.bioorg.2025.108903_bb0005","doi-asserted-by":"crossref","first-page":"778","DOI":"10.1353\/pbm.2019.0046","article-title":"What is Cancer?","volume":"62","author":"Hausman","year":"2019","journal-title":"Perspect. Biol. Med."},{"key":"10.1016\/j.bioorg.2025.108903_bb0010","doi-asserted-by":"crossref","DOI":"10.1016\/j.lfs.2020.118999","article-title":"Polyphenolic molecules targeting STAT3 pathway for the treatment of cancer","volume":"268","author":"Aziz","year":"2021","journal-title":"Life Sci."},{"issue":"6","key":"10.1016\/j.bioorg.2025.108903_bb0015","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1038\/cgt.2017.16","article-title":"New methods in the diagnosis of cancer and gene therapy of cancer based on nanoparticles","volume":"24","author":"Zaimy","year":"2017","journal-title":"Cancer Gene Ther."},{"issue":"1","key":"10.1016\/j.bioorg.2025.108903_bb0020","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1158\/1055-9965.EPI-15-0578","article-title":"Global cancer incidence and mortality rates and trends\u2014an update","volume":"25","author":"Torre","year":"2016","journal-title":"Cancer Epidemiol. Biomarkers Prev."},{"issue":"5","key":"10.1016\/j.bioorg.2025.108903_bb0025","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1016\/j.cell.2011.02.013","article-title":"Hallmarks of cancer: the next generation","volume":"144","author":"Hanahan","year":"2011","journal-title":"Cell"},{"issue":"7","key":"10.1016\/j.bioorg.2025.108903_bb0030","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1016\/j.ctrv.2012.04.006","article-title":"Role of angiogenesis in the pathogenesis of cancer","volume":"38","author":"Hoff","year":"2012","journal-title":"Cancer Treat. Rev."},{"issue":"2","key":"10.1016\/j.bioorg.2025.108903_bb0035","doi-asserted-by":"crossref","DOI":"10.3390\/biomedicines5020034","article-title":"The role of angiogenesis in cancer treatment","volume":"5","author":"Rajabi","year":"2017","journal-title":"Biomedicines"},{"issue":"11","key":"10.1016\/j.bioorg.2025.108903_bb0040","doi-asserted-by":"crossref","DOI":"10.3390\/ijms20112676","article-title":"Targeting angiogenesis in prostate Cancer","volume":"20","author":"Melegh","year":"2019","journal-title":"Int. J. Mol. Sci."},{"issue":"2","key":"10.1016\/j.bioorg.2025.108903_bb0045","first-page":"455","article-title":"Vascular endothelial growth factor (VEGF) - key factor in normal and pathological angiogenesis","volume":"59","author":"Melincovici","year":"2018","journal-title":"Romanian J. Morphol. Embryol."},{"issue":"6","key":"10.1016\/j.bioorg.2025.108903_bb0050","article-title":"Tumour angiogenesis and angiogenic inhibitors: a review","volume":"9","author":"Yadav","year":"2015","journal-title":"J. Clin. Diagn. Res."},{"issue":"42","key":"10.1016\/j.bioorg.2025.108903_bb0055","doi-asserted-by":"crossref","first-page":"6549","DOI":"10.1038\/sj.onc.1206816","article-title":"Molecular basis of angiogenesis and cancer","volume":"22","author":"Tonini","year":"2003","journal-title":"Oncogene"},{"issue":"4","key":"10.1016\/j.bioorg.2025.108903_bb0060","first-page":"222","article-title":"Angiogenesis inhibitors: current strategies and future prospects","volume":"60","author":"Cook","year":"2010","journal-title":"CA Cancer J. Clin."},{"issue":"1","key":"10.1016\/j.bioorg.2025.108903_bb0065","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1038\/s41392-023-01460-1","article-title":"Angiogenic signaling pathways and anti-angiogenic therapy for cancer","volume":"8","author":"Liu","year":"2023","journal-title":"Signal Transduct. Target. Ther."},{"issue":"13","key":"10.1016\/j.bioorg.2025.108903_bb0070","doi-asserted-by":"crossref","DOI":"10.3390\/cancers13133253","article-title":"New Angiogenic regulators produced by TAMs: perspective for targeting tumor angiogenesis","volume":"13","author":"Larionova","year":"2021","journal-title":"Cancers (Basel)"},{"issue":"20","key":"10.1016\/j.bioorg.2025.108903_bb0075","doi-asserted-by":"crossref","first-page":"4034","DOI":"10.1111\/bph.14813","article-title":"A novel 2-aminobenzimidazole-based compound Jzu 17 exhibits anti-angiogenesis effects by targeting VEGFR-2 signalling","volume":"176","author":"Lien","year":"2019","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.bioorg.2025.108903_bb0080","article-title":"Resibufogenin suppresses triple-negative breast Cancer angiogenesis by blocking VEGFR2-mediated signaling pathway","volume":"12","author":"Yang","year":"2021","journal-title":"Front. Pharmacol."},{"issue":"9","key":"10.1016\/j.bioorg.2025.108903_bb0085","doi-asserted-by":"crossref","DOI":"10.3390\/ijms23095245","article-title":"PLATO: a predictive drug discovery web platform for efficient target fishing and bioactivity profiling of small molecules","volume":"23","author":"Ciriaco","year":"2022","journal-title":"Int. J. Mol. Sci."},{"issue":"1","key":"10.1016\/j.bioorg.2025.108903_bb0090","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1186\/s12860-021-00367-5","article-title":"sFLT01 modulates invasion and metastasis in prostate cancer DU145 cells by inhibition of VEGF\/GRP78\/MMP2&9 axis","volume":"22","author":"Taghizadeh","year":"2021","journal-title":"BMC Mol. Cell Biol."},{"issue":"3","key":"10.1016\/j.bioorg.2025.108903_bb0095","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1038\/s41419-022-04620-3","article-title":"Bevacizumab attenuates osteosarcoma angiogenesis by suppressing MIAT encapsulated by serum-derived extracellular vesicles and facilitating miR-613-mediated GPR158 inhibition","volume":"13","author":"Wang","year":"2022","journal-title":"Cell Death Dis."},{"issue":"2","key":"10.1016\/j.bioorg.2025.108903_bb0100","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1016\/j.bbrc.2007.02.156","article-title":"Sunitinib: a VEGF and PDGF receptor protein kinase and angiogenesis inhibitor","volume":"356","author":"Roskoski","year":"2007","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"10","key":"10.1016\/j.bioorg.2025.108903_bb0105","doi-asserted-by":"crossref","first-page":"3129","DOI":"10.1158\/1535-7163.MCT-08-0013","article-title":"Preclinical overview of sorafenib, a multikinase inhibitor that targets both Raf and VEGF and PDGF receptor tyrosine kinase signaling","volume":"7","author":"Wilhelm","year":"2008","journal-title":"Mol. Cancer Ther."},{"issue":"7","key":"10.1016\/j.bioorg.2025.108903_bb0110","first-page":"1489","article-title":"The role of angiogenesis inhibitors re-challenge in colorectal cancer previously treated with bevacizumab: a meta-analysis of randomized controlled trials","volume":"21","author":"Xiong","year":"2017","journal-title":"Eur. Rev. Med. Pharmacol. Sci."},{"issue":"5","key":"10.1016\/j.bioorg.2025.108903_bb0115","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1080\/13543784.2018.1472235","article-title":"Lenvatinib for the treatment of renal cell carcinoma","volume":"27","author":"Roviello","year":"2018","journal-title":"Expert Opin. Investig. Drugs"},{"issue":"2","key":"10.1016\/j.bioorg.2025.108903_bb0120","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1016\/j.bbrc.2015.06.126","article-title":"1-o-acetylbritannilactone (ABL) inhibits angiogenesis and lung cancer cell growth through regulating VEGF-Src-FAK signaling","volume":"464","author":"Zhengfu","year":"2015","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"1","key":"10.1016\/j.bioorg.2025.108903_bb0125","doi-asserted-by":"crossref","first-page":"11070","DOI":"10.1038\/s41598-020-67993-5","article-title":"Robustaflavone induces G0\/G1 cell cycle arrest and apoptosis in human umbilical vein endothelial cells and exhibits anti-angiogenic effects in vivo","volume":"10","author":"Sim","year":"2020","journal-title":"Sci. Rep."},{"issue":"5706","key":"10.1016\/j.bioorg.2025.108903_bb0130","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1126\/science.1104819","article-title":"Normalization of tumor vasculature: an emerging concept in antiangiogenic therapy","volume":"307","author":"Jain","year":"2005","journal-title":"Science"},{"issue":"5","key":"10.1016\/j.bioorg.2025.108903_bb0135","first-page":"15","article-title":"Cost and selection of ophthalmic anti-vascular endothelial growth factor agents","volume":"99","author":"Li","year":"2013","journal-title":"R. I. Med. J."},{"key":"10.1016\/j.bioorg.2025.108903_bb0140","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2021.104842","article-title":"Discovery of pyridine- sulfonamide hybrids as a new scaffold for the development of potential VEGFR-2 inhibitors and apoptosis inducers","volume":"111","author":"Ahmed","year":"2021","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.bioorg.2025.108903_bb0145","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2023.115647","article-title":"Exploring the 1,3-benzoxazine chemotype for cannabinoid receptor 2 as a promising anti-cancer therapeutic","volume":"259","author":"Gambacorta","year":"2023","journal-title":"Eur. J. Med. Chem."},{"issue":"24","key":"10.1016\/j.bioorg.2025.108903_bb0150","doi-asserted-by":"crossref","DOI":"10.3390\/ijms232415585","article-title":"The VEGF\/VEGFR Axis revisited: implications for Cancer therapy","volume":"23","author":"Mabeta","year":"2022","journal-title":"Int. J. Mol. Sci."},{"issue":"11","key":"10.1016\/j.bioorg.2025.108903_bb0155","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1038\/s41580-023-00631-w","article-title":"Biology and therapeutic targeting of vascular endothelial growth factor a","volume":"24","author":"P\u00e9rez-Guti\u00e9rrez","year":"2023","journal-title":"Nat. Rev. Mol. Cell Biol."},{"issue":"21","key":"10.1016\/j.bioorg.2025.108903_bb0160","doi-asserted-by":"crossref","first-page":"4368","DOI":"10.1200\/JCO.2002.10.088","article-title":"Vascular permeability factor\/vascular endothelial growth factor: a critical cytokine in tumor angiogenesis and a potential target for diagnosis and therapy","volume":"20","author":"Dvorak","year":"2002","journal-title":"J. Clin. Oncol."},{"issue":"5","key":"10.1016\/j.bioorg.2025.108903_bb0165","doi-asserted-by":"crossref","first-page":"360","DOI":"10.3892\/etm.2022.11287","article-title":"Sinensetin suppresses angiogenesis in liver cancer by targeting the VEGF\/VEGFR2\/AKT signaling pathway","volume":"23","author":"Li","year":"2022","journal-title":"Exp. Ther. Med."},{"issue":"10","key":"10.1016\/j.bioorg.2025.108903_bb0170","first-page":"3149","article-title":"A VEGFR1 antagonistic peptide inhibits tumor growth and metastasis through VEGFR1-PI3K-AKT signaling pathway inhibition","volume":"5","author":"Zhou","year":"2015","journal-title":"Am. J. Cancer Res."},{"issue":"59","key":"10.1016\/j.bioorg.2025.108903_bb0175","doi-asserted-by":"crossref","DOI":"10.1126\/scisignal.259re1","article-title":"Positive and negative modulation of angiogenesis by VEGFR1 ligands","volume":"2","author":"Cao","year":"2009","journal-title":"Sci. Signal."},{"issue":"12","key":"10.1016\/j.bioorg.2025.108903_bb0180","doi-asserted-by":"crossref","first-page":"942","DOI":"10.1038\/nrc2524","article-title":"FLT1 and its ligands VEGFB and PlGF: drug targets for anti-angiogenic therapy?","volume":"8","author":"Fischer","year":"2008","journal-title":"Nat. Rev. Cancer"},{"issue":"7347","key":"10.1016\/j.bioorg.2025.108903_bb0185","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1038\/nature10144","article-title":"Molecular mechanisms and clinical applications of angiogenesis","volume":"473","author":"Carmeliet","year":"2011","journal-title":"Nature"},{"issue":"7","key":"10.1016\/j.bioorg.2025.108903_bb0190","doi-asserted-by":"crossref","DOI":"10.1101\/cshperspect.a006502","article-title":"Signal transduction by vascular endothelial growth factor receptors","volume":"2","author":"Koch","year":"2012","journal-title":"Cold Spring Harb. Perspect. Med."},{"issue":"1","key":"10.1016\/j.bioorg.2025.108903_bb0195","doi-asserted-by":"crossref","first-page":"1","DOI":"10.4062\/biomolther.2013.113","article-title":"VEGF-VEGFR signals in health and disease","volume":"22","author":"Shibuya","year":"2014","journal-title":"Biomol. Ther. (Seoul)"},{"issue":"6","key":"10.1016\/j.bioorg.2025.108903_bb0200","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1016\/j.tips.2006.04.006","article-title":"Angiogenesis: from plants to blood vessels","volume":"27","author":"Fan","year":"2006","journal-title":"Trends Pharmacol. Sci."},{"issue":"4","key":"10.1016\/j.bioorg.2025.108903_bb0205","doi-asserted-by":"crossref","first-page":"628","DOI":"10.1038\/nprot.2010.6","article-title":"In vitro angiogenesis: endothelial cell tube formation on gelled basement membrane extract","volume":"5","author":"Arnaoutova","year":"2010","journal-title":"Nat. Protoc."},{"issue":"2","key":"10.1016\/j.bioorg.2025.108903_bb0210","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1007\/s12272-014-0386-5","article-title":"Antiangiogenic effects of cucurbitacin-I","volume":"38","author":"Kim","year":"2015","journal-title":"Arch. Pharm. Res."},{"issue":"6","key":"10.1016\/j.bioorg.2025.108903_bb0215","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1038\/nrd3455","article-title":"Principles and mechanisms of vessel normalization for cancer and other angiogenic diseases","volume":"10","author":"Carmeliet","year":"2011","journal-title":"Nat. Rev. Drug Discov."},{"issue":"3","key":"10.1016\/j.bioorg.2025.108903_bb0220","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1111\/j.1365-2613.2008.00633.x","article-title":"A critical analysis of current in vitro and in vivo angiogenesis assays","volume":"90","author":"Staton","year":"2009","journal-title":"Int. J. Exp. Pathol."},{"key":"10.1016\/j.bioorg.2025.108903_bb0225","article-title":"A critical analysis of the available","volume":"2017","author":"Moleiro","year":"2017","journal-title":"J. Ophthalmol."},{"issue":"12","key":"10.1016\/j.bioorg.2025.108903_bb0230","doi-asserted-by":"crossref","first-page":"9104","DOI":"10.3390\/molecules15129104","article-title":"Experimental models for assaying microvascular endothelial cell pathophysiology in stroke","volume":"15","author":"Cam\u00f3s","year":"2010","journal-title":"Molecules"},{"issue":"5","key":"10.1016\/j.bioorg.2025.108903_bb0235","doi-asserted-by":"crossref","DOI":"10.3892\/ijmm.2025.5518","article-title":"Hesperetin induces apoptosis in lung squamous carcinoma cells via G","volume":"55","author":"Xie","year":"2025","journal-title":"Int. J. Mol. Med."},{"issue":"4","key":"10.1016\/j.bioorg.2025.108903_bb0240","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1016\/j.dental.2015.01.007","article-title":"Cytotoxicity of dimethyl sulfoxide (DMSO) in direct contact with odontoblast-like cells","volume":"31","author":"Hebling","year":"2015","journal-title":"Dent. Mater."},{"issue":"6","key":"10.1016\/j.bioorg.2025.108903_bb0245","first-page":"1721","article-title":"microRNA-21 modulates cell proliferation and sensitivity to doxorubicin in bladder cancer cells","volume":"25","author":"Tao","year":"2011","journal-title":"Oncol. Rep."},{"issue":"5","key":"10.1016\/j.bioorg.2025.108903_bb0250","doi-asserted-by":"crossref","first-page":"1610","DOI":"10.1021\/jm049538w","article-title":"Discovery and evaluation of 2-anilino-5-aryloxazoles as a novel class of VEGFR2 kinase inhibitors","volume":"48","author":"Harris","year":"2005","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.bioorg.2025.108903_bb0255","unstructured":"L. Tresaugues, Crystal structure of VEGFR1 in complex with N-(4-Chlorophenyl)-2-((pyridin-4-ylmethyl)amino)benzamide, A. Roos, Editor, 2023: PDB Entry - 3HNG, https:\/\/ncbiinsights.ncbi.nlm.nih.gov\/2025\/07\/08\/ncbi-website-maintenance-july-26th\/."},{"key":"10.1016\/j.bioorg.2025.108903_bb0260","unstructured":"R. Schr\u00f6dinger, Protein Preparation Wizard; Epik, Schr\u00f6dinger, LLC, New York, NY, 2023; Impact, Schr\u00f6dinger, LLC, New York, NY; Prime, Schr\u00f6dinger, LLC, New York, NY, 2023, https:\/\/www.schrodinger.com\/life-science\/learn\/white-papers\/protein-preparation-workflow\/."},{"key":"10.1016\/j.bioorg.2025.108903_bb0265","series-title":"LigPrep","author":"Schr\u00f6dinger","year":"2023"},{"issue":"7","key":"10.1016\/j.bioorg.2025.108903_bb0270","doi-asserted-by":"crossref","first-page":"1739","DOI":"10.1021\/jm0306430","article-title":"Glide: a new approach for rapid, accurate docking and scoring. 1. Method and assessment of docking accuracy","volume":"47","author":"Friesner","year":"2004","journal-title":"J. Med. Chem."},{"issue":"7","key":"10.1016\/j.bioorg.2025.108903_bb0275","doi-asserted-by":"crossref","first-page":"4291","DOI":"10.1021\/acs.jctc.1c00302","article-title":"OPLS4: improving force field accuracy on challenging regimes of chemical space","volume":"17","author":"Lu","year":"2021","journal-title":"J. Chem. Theory Comput."},{"key":"10.1016\/j.bioorg.2025.108903_bb0280","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1007\/978-1-4939-9133-4_17","article-title":"In vitro spheroid sprouting assay of angiogenesis","volume":"1952","author":"Zahra","year":"2019","journal-title":"Methods Mol. Biol."}],"container-title":["Bioorganic Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0045206825007837?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0045206825007837?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,12]],"date-time":"2025-09-12T05:48:52Z","timestamp":1757656132000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0045206825007837"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9]]},"references-count":56,"alternative-id":["S0045206825007837"],"URL":"https:\/\/doi.org\/10.1016\/j.bioorg.2025.108903","relation":{},"ISSN":["0045-2068"],"issn-type":[{"value":"0045-2068","type":"print"}],"subject":[],"published":{"date-parts":[[2025,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Synthesis and evaluation of sulfonamide-chalcone hybrid compounds as inhibitors of VEGFR1\/VEGFR2-mediated angiogenesis","name":"articletitle","label":"Article Title"},{"value":"Bioorganic Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bioorg.2025.108903","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"108903"}}